News
Suarez pleaded guilty to conspiring to commit bank and mail fraud, along with aggravated identity theft. He faces several ...
13h
Zacks Investment Research on MSNKALV Stock Moves More Than 30% in a Week: What Is Driving This Rally?Shares of KalVista Pharmaceuticals KALV have soared 36% in the past week, all thanks to the FDA’s approval of its lead ...
KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced that the U.S. Food and Drug Administration (FDA) has approved EKTERLY® (sebetralstat), a novel ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results